Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 17 - Number 1




Review Article

Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma

, 17(1): 17 - 39

Gang Wang, Xing-Li Fu, Jun-Jie Wang, Rui Guan and Xiang-Jun Tang


DOI: 10.2174/1568009616666160512145436



Review Article

OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted Therapy

, 17(1): 40 - 47

Nana Zheng, Ping Yang, Zhiwei Wang and Quansheng Zhou


DOI: 10.2174/1568009616666160216130608




Review Article

UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6): Role in Cancer and Prospects as a Drug Target

, 17(1): 53 - 61

Samantha Banford and David J. Timson


DOI: 10.2174/1568009616666160922102641



Research Article

Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?

, 17(1): 62 - 73

Sofia Braga, Joana Cardoso, Saudade Andre, Margarida Brito, Pedro Sanchez, Lurdes Orvalho, Lucilia Salgado, Sergio Dias, Jose B. Pereira-Leal and Jose Luis Passos-Coelho


DOI: 10.2174/1568009616666161025114914



Research Article

Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets

, 17(1): 74 - 88

Himanshi Kapoor, Nalini Yadav, Madhu Chopra, Sushil Chandra Mahapatra and Veena Agrawal


DOI: 10.2174/1570163813666161019143740



Research Article

EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo

, 17(1): 89 - 97

Chenfei Zhou, Liangjun Zhu, Jun Ji, Fangmi Ding, Chao Wang, Qu Cai, Yingyan Yu, Zhenggang Zhu and Jun Zhang


DOI: 10.2174/1568009616666161013101657




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

Sep-2021-ban

Related Journals

Related eBooks

eBooks Catalog